Armonica Technologies

CARLSBAD, Calif., May 29, 2024 /PRNewswire/ — Armonica, a pioneer in optical epigenetic sequencing has appointed Emily Milsovic as its new chief executive officer (CEO), effective immediately.  Ms. Milsovic succeeds Victor Esch, Ph.D., as part of a planned leadership transition as he retires. Ms. Milsovic will remain a member of the Armonica Board of Directors. […]

SAN DIEGO, March 13, 2024 /PRNewswire/ — Armonica Technologies, Inc., a pioneer in sample-prep free direct optical DNA sequencing, today announced the appointment of life science leader Todd Dickinson to the Board of Directors. Armonica Technologies is a MedTech company focused on developing its advanced long-read sequencing platform for precision medicine applications. The company utilizes nanochannels

SAN DIEGO, Feb. 26, 2024 /PRNewswire/ — Armonica Technologies, Inc., a pioneer in sample-prep free direct optical DNA sequencing, today announced the appointment of biotech veteran Emily Milsovic to the Board of Directors. Armonica Technologies is a MedTech company focused on developing its advanced long-read sequencing platform for precision medicine applications. The company utilizes nanochannels to

By Kevin Robinson-Avila / Journal Staff Writer Published: Sunday, October 2nd, 2022 at 9:02PM Updated: Monday, October 3rd, 2022 at 12:02AM   Technology to rapidly read long strands of DNA with accurate, molecular-level precision has eluded researchers for decades. But an Albuquerque startup is close to achieving that breakthrough in genomic sequencing, now backed by

ALBUQUERQUE, N.M., Oct. 18, 2021 /PRNewswire/ — Armonica Technologies, Inc., a biotechnology company developing a high throughput, direct long-read DNA sequencing technology, announced that it has raised $2M in new funding.  The financing included Hamamatsu Photonics K.K. and current investors Cottonwood Technology Fund, Sun Mountain Capital and Tramway Venture Partners. The funding will support further feasibility demonstration of company’s

ALBUQUERQUE, N.M., March 29, 2021 /PRNewswire/ — Armonica Technologies, Inc., a biotechnology company developing a novel DNA sequencing system based on nano-structure devices, announced that the company has been awarded an SBIR grant from the NIH’s National Human Genome Research Institute for “Single molecule DNA/RNA transport and Raman scattering readout in a coupled nanochannel/nanopore sequencing system.”  The award

ALBUQUERQUE, N.M., Nov. 14, 2018 /PRNewswire/ — Armonica Technologies, Inc, an Albuquerque, NM-based company focused on building its proprietary long-read DNA sequencing technology (the “Company”), chalked up new Intellectual Property success in 2018 by securing two new patents covering its innovative approach. As it advances the stage of its technology, the Company is generating excitement within the

SAN FRANCISCO (GenomeWeb) – Armonica Technologies, a startup that has spun out of the University of New Mexico, is looking to develop nanopore sequencing technology that relies on stretching DNA through nanochannels that have a porous roof. In August, the firm received $1.5 million in seed investment from New Mexico’s Catalyst Fund. The nanopore technology

Armonica Technologies, Inc., an STC.UNM startup commercializing new technology that promises to be a gigantic leap in genomic sequencing capabilities, has received a $1.5 million investment from the state’s Catalyst Fund and local private investors Cottonwood Technology Funds and Tramway Venture Partners.  The technology is being developed by UNM Distinguished Professor Emeritus Steven Brueck, Professor

Today, DNA sequencing is a tortuous process that often takes days and sometimes weeks to read a full human genome, but University of New Mexico researchers may have found a way to cut that down to minutes. Investors are now lining up behind UNM’s breakthrough, which they say could accelerate the healthcare industry’s use of